Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyethyl Starch vs Crystalloid Coload With Norepinephrine for Postspinal Anesthesia Hypotension in Caesarean Section
NCT05475990Completed
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Jan 2023
- Primary completion
- Mar 2023
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of hetastarch, cold crystalloid solution and norepinephrine in hypotension (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoint: Effective Dose 50 and Effective Dose 90. Started Jan 2023; status: completed.
02
Drugs
hetastarchcold crystalloid solutionnorepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05475990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05475990.